{"id":4731,"date":"2025-01-03T11:15:01","date_gmt":"2025-01-03T01:15:01","guid":{"rendered":"\/eu-uk\/?p=4731"},"modified":"2025-01-20T11:16:26","modified_gmt":"2025-01-20T01:16:26","slug":"podcast-talk-ya-book","status":"publish","type":"post","link":"\/eu-uk\/blog\/2025\/01\/03\/podcast-talk-ya-book\/","title":{"rendered":"Podcast | Talk Ya Book"},"content":{"rendered":"<p>Orthocell Chairman <a id=\"ember731\" class=\"ember-view\" href=\"https:\/\/www.linkedin.com\/in\/john-van-der-wielen-6b3b8313b\/\">John Van Der Wielen<\/a> recently spoke with podcast host <a id=\"ember732\" class=\"ember-view\" href=\"https:\/\/www.linkedin.com\/in\/chris-judd-3897611b3\/\">Chris Judd<\/a> on Talk Ya Book to discuss the Company&#8217;s journey and exciting plans for global expansion with its regenerative medicine technologies.<\/p>\n<p>From his experience during the GFC at Lloyd&#8217;s Banking Group to leading Orthocell&#8217;s strategic expansion, John shares valuable insights on building a sustainable healthcare company. He discusses Orthocell&#8217;s innovative nerve repair technology, its strong manufacturing capabilities, and the significant market opportunity ahead, particularly in the US.<\/p>\n<p>&#8220;The majority of biotechs do not manufacture their own product. They invent the product, they do the research, but we&#8217;ve built the manufacturing labs in Western Australia. We&#8217;ve got capacity to produce about 100,000 units, and a nice problem to have is that we have to add another module to produce more product. But the benefit for it as an investor is we own that manufacturing margin&#8230; and that&#8217;s incredibly powerful.&#8221;<\/p>\n<p>Have a listen:<\/p>\n<p><iframe loading=\"lazy\" style=\"border-radius: 12px;\" src=\"https:\/\/open.spotify.com\/embed\/episode\/0fyss2GmtoAaYEhbbAhX5c?utm_source=generator\" width=\"100%\" height=\"152\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell Chairman John Van Der Wielen recently spoke with podcast host Chris Judd on Talk Ya Book to discuss the Company&#8217;s journey and exciting plans for global expansion with its regenerative medicine technologies.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-4731","post","type-post","status-publish","format-standard","hentry","category-media"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4731"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4731\/revisions"}],"predecessor-version":[{"id":4733,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4731\/revisions\/4733"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4731"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}